Omeros Corporation (OMER)

Dec 10, 2025

Omeros Corporation (OMER): Novo Nordisk Deal Creating Buzz - Insider Monkey

Dec 10, 2025

Dec 09, 2025

Omeros Corporation's (NASDAQ:OMER) Shift From Loss To Profit - Yahoo Finance

Dec 09, 2025

Dec 08, 2025

Do You Believe Omeros Corporation’s (OMER) New Monoclonal Antibody Has Strong Chances of Approval? - Insider Monkey

Dec 08, 2025

Dec 06, 2025

Omeros Completes Major Asset Deal with Novo Nordisk - MSN

Dec 06, 2025

Dec 05, 2025

Is Omeros Corporation (OMER) One of the Hot Stocks to Buy with Huge Upside Potential? - MSN

Dec 05, 2025

Dec 05, 2025

Omeros Corp Sells Immune-System Drug To Novo Nordisk In $2.1B Deal — Retail Shifts Focus To Narsoplimab FDA Call - MSN

Dec 05, 2025

Dec 04, 2025

Omeros (NASDAQ:OMER) Stock Price Up 8.2%Still a Buy? - MarketBeat

Dec 04, 2025

Dec 04, 2025

Can Omeros Corporation stock outperform in 2025 bull marketJuly 2025 Update & Short-Term High Return Ideas - Newser

Dec 04, 2025

Dec 04, 2025

11 Best Micro-Cap Stocks to Invest in According to Analysts - Insider Monkey

Dec 04, 2025

Dec 02, 2025

Omeros (NASDAQ:OMER) Given Buy Rating at D. Boral Capital - MarketBeat

Dec 02, 2025

Dec 02, 2025

Aug Sentiment: Is Omeros Corporation stock attractive for income investorsMarket Volume Report & Smart Allocation Stock Tips - BỘ NỘI VỤ

Dec 02, 2025

Dec 02, 2025

How Omeros Corporation stock performs in weak economyChart Signals & Entry Point Confirmation Alerts - Newser

Dec 02, 2025

Dec 01, 2025

Omeros (OMER) Receives Consistent 'Buy' Rating from D. Boral Cap - GuruFocus

Dec 01, 2025

Dec 01, 2025

Omeros Shares Jump After Finalizing $340 Million Novo Nordisk Deal - MSN

Dec 01, 2025

Dec 01, 2025

Omeros (OMER) Secures $2.1B Deal with Novo Nordisk - GuruFocus

Dec 01, 2025

Dec 01, 2025

Omeros Closes Asset Purchase, Licensing Deal With Novo Nordisk for Zaltenibart - MarketScreener

Dec 01, 2025

Dec 01, 2025

Omeros, Novo Nordisk Close Up to $2.1B Deal for Rare Disease Drug Zaltenibart, NOVO Stock - Somos Hermanos -

Dec 01, 2025

Dec 01, 2025

Omeros, Novo Nordisk close up to $2.1B deal for phase 2 asset zaltenibart - MSN

Dec 01, 2025

Dec 01, 2025

Omeros receives $240 million upfront from Novo Nordisk deal By Investing.com - Investing.com Canada

Dec 01, 2025

Dec 01, 2025

Omeros receives $240 million upfront from Novo Nordisk deal - Investing.com

Dec 01, 2025

Dec 01, 2025

Omeros stock surges after closing $340 million deal with Novo Nordisk - Investing.com Australia

Dec 01, 2025

Dec 01, 2025

Omeros stock surges after closing $340 million deal with Novo Nordisk By Investing.com - Investing.com South Africa

Dec 01, 2025

Dec 01, 2025

Omeros closes asset purchase and license deal with Novo Nordisk for MASP-3 inhibitor zaltenibart - marketscreener.com

Dec 01, 2025

Dec 01, 2025

Omeros Corporation Announces Closing of Asset Purchase and License Agreement with Novo Nordisk for Omeros’ Clinical-Stage MASP-3 Inhibitor Zaltenibart (OMS906) - Yahoo Finance

Dec 01, 2025

Nov 29, 2025

Omeros Corporation (NASDAQ:OMER): When Will It Breakeven? - simplywall.st

Nov 29, 2025

Nov 28, 2025

What catalysts could drive Omeros Corporation stock higher2025 Short Interest & Weekly Top Stock Performers List - moha.gov.vn

Nov 28, 2025

Nov 27, 2025

Omeros jumps as lead drug succeeds in pivotal trial for blood transplant patients - MSN

Nov 27, 2025

Nov 26, 2025

Omeros (NASDAQ:OMER) Shares Pass Above 200 Day Moving AverageHere's Why - MarketBeat

Nov 26, 2025

Nov 21, 2025

Omeros: Key Milestone Ahead, Risk-Averse Investors Should Avoid (NASDAQ:OMER) - Seeking Alpha

Nov 21, 2025

Nov 21, 2025

What technical signals suggest for Omeros Corporation stockMarket Performance Recap & Real-Time Volume Trigger Notifications - newser.com

Nov 21, 2025

Nov 20, 2025

Omeros Corporation Stock Analysis and ForecastInsider Selling Patterns & Free Stock Trading Workshops - earlytimes.in

Nov 20, 2025

Nov 20, 2025

Is Omeros Corporation stock cheap compared to fundamentalsIPO Watch & Technical Entry and Exit Tips - newser.com

Nov 20, 2025

Nov 19, 2025

Omeros gets FDA acceptance for narsoplimab BLA resubmission - MSN

Nov 19, 2025

Nov 19, 2025

Omeros (NASDAQ:OMER) Shares Down 5.6%Should You Sell? - MarketBeat

Nov 19, 2025

Nov 19, 2025

Here's Why Shares in Theravance Biopharma Exploded Today - AOL.com

Nov 19, 2025

Nov 19, 2025

Why Shares in Arrowhead Pharmaceuticals Surged on News of a Novartis Deal - AOL.com

Nov 19, 2025

Nov 19, 2025

How strong is Omeros Corporation stock revenue growthBuy Signal & Fast Exit/Entry Strategy Plans - newser.com

Nov 19, 2025

Nov 18, 2025

This Fund Sold $30 Million in PTC Therapeutics Shares Amid a 93% Rally: Here’s Why - AOL.com

Nov 18, 2025

Nov 18, 2025

Omeros (NASDAQ:OMER) Stock Price Up 8.1%Time to Buy? - MarketBeat

Nov 18, 2025

Nov 18, 2025

Omeros Corporation (NASDAQ:OMER) Q3 2025 Earnings Call Transcript - Insider Monkey

Nov 18, 2025

Nov 17, 2025

Centessa Stock Has Surged 77% Over the Past Year — But a Top Biotech Fund Is Still Buying - AOL.com

Nov 17, 2025

Nov 17, 2025

This Biotech Fund Made a New $40 Million Bet on Liquidia Amid Blockbuster Commercial Drug Launch - AOL.com

Nov 17, 2025

Nov 17, 2025

Omeros Corporation’s Earnings Call Highlights Strategic Moves - TipRanks

Nov 17, 2025

Nov 17, 2025

test-commerce-234 - AOL.com

Nov 17, 2025

Nov 17, 2025

Omeros (OMER) Q3 2025 Earnings Call Transcript - The Globe and Mail

Nov 17, 2025